Price$24.38-0.09 (-0.37%)
02:00 PM07:45 PM
News · 26 weeks48-73%
2025-12-072026-05-31
Mix2990d
- Insider11(38%)
- SEC Filings9(31%)
- Other4(14%)
- Leadership2(7%)
- Earnings2(7%)
- Offering1(3%)
Latest news
25 items- PRTactile Medical Launches Next-Generation AffloVest® Airway Clearance TherapyMINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation (HFCWO) therapy system. The next-generation system maintains its indication for use as a treatment option for chronic neuromuscular and respiratory conditions, including cystic fibrosis and bronchiectasis, across pediatric and geriatric populations, while introducing enhancements to patient comfort, ease of use, and connected care capabilities to support long-term therapy
- PRTactile Medical to Present at the William Blair 46th Annual Growth Stock ConferenceMINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time. A live audio webcast of the presentation will be accessible under the "Events & Webcasts" section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for
- INSIDERCHIEF FINANCIAL OFFICER Birkemeyer Elaine M. sold $113,404 worth of shares (4,631 units at $24.49), decreasing direct ownership by 3% to 130,188 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- SECSEC Form 144 filed by Tactile Systems Technology Inc.144 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)
- INSIDERDirector Asbury Valerie L. was granted 6,521 shares, increasing direct ownership by 13% to 55,343 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Huggenberger Raymond was granted 6,521 shares, increasing direct ownership by 12% to 62,841 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector King Laura G. was granted 6,521 shares, increasing direct ownership by 34% to 25,569 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Pearson Andrea was granted 6,521 shares, increasing direct ownership by 765% to 7,373 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Shafer David Brent was granted 6,521 shares, increasing direct ownership by 13% to 55,343 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Volkart Carmen B was granted 6,521 shares, increasing direct ownership by 17% to 44,219 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Washington Boyd Vindell was granted 6,521 shares, increasing direct ownership by 19% to 41,768 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- INSIDERDirector Burke William W was granted 6,521 shares, increasing direct ownership by 13% to 55,041 units (SEC Form 4)4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- ANALYSTTactile Systems upgraded by B. Riley Securities with a new price targetB. Riley Securities upgraded Tactile Systems from Neutral to Buy and set a new price target of $36.00
- SECSEC Form S-8 filed by Tactile Systems Technology Inc.S-8 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- SECSEC Form 10-Q filed by Tactile Systems Technology Inc.10-Q - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- SECTactile Systems Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- PRTactile Systems Technology, Inc. Reports First Quarter 2026 Financial ResultsMINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 23% year-over-year to $75.3 millionGross margin of 76.5% versus 74% in Q1 2025Net loss of $1.8 million versus $3.0 million in Q1 2025Adjusted EBITDA of $3.7 million versus an Adjusted EBITDA loss of $0.3 million in Q1 2025Expanded AI-enabled order management platform with the implementation of new operational capabilities
- PRTactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2026 financial results will be released after the market closes on Monday, May 4, 2026. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 4, 2026, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13759535. A live webcast of the call will also be provided on the
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Tactile Systems Technology Inc.SCHEDULE 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)
- SECSEC Form DEFA14A filed by Tactile Systems Technology Inc.DEFA14A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- SECSEC Form DEF 14A filed by Tactile Systems Technology Inc.DEF 14A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)
- PRNeuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsTotal revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37% on an adjusted pro forma basis versus Q4 2024 Continued cash management improvement, with cash provided by operations of $0.9 million in Q4 2025 Expect full year 2026 revenue of between $160 million and $166 million Dan Reuvers appointed as President and Chief Executive Officer, effective March 23, 2026; proven medical device leader with more than 30 years of experience scaling commercial healthcare businesses MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ:STIM
- PRNeuronetics Appoints Dan Reuvers as President and Chief Executive OfficerMALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin
- INSIDERSEC Form 3 filed by Tactile Systems Technology Inc.3 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)
TCMD FAQ
7 questionsWhat does Tactile Systems Technology Inc. do?
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.Where does TCMD stock trade?
Tactile Systems Technology Inc. (TCMD) is listed on NASDAQ.What sector and industry is TCMD in?
Tactile Systems Technology Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Tactile Systems Technology Inc. go public?
Tactile Systems Technology Inc. (TCMD) completed its IPO in 2016.What are analysts saying about TCMD?
Tactile Systems Technology Inc. has had 8 recent analyst actions on file. The most recent action was from B. Riley Securities: Buy with a $3600.00 price target on 2026-05-07. Recent price targets range from $1400.00 to $3600.00.What companies are similar to TCMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare TCMD side-by-side with any of them on Quantisnow.How can I track TCMD on Quantisnow?
Quantisnow aggregates Tactile Systems Technology Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TCMD to receive live email and push alerts on every new disclosure.